Document
Cannabinoids; chloroplast transformation; heterologous expression; microalgae; nuclear transformation; synthetic biology Genetic engineering; Microorganisms; Synthetic biology; Bioactives; Biosynthetic pathway; Cannabinoids; Chloroplast transformation; Heterologous expression; Heterologous systems; Medicinal plants; Micro-algae; Nuclear transformations; Synthetic biology; Microalgae
Harnessing the advances of genetic engineering in microalgae for the production of cannabinoids
Cannabis is widely recognized as a medicinal plant owing to bioactive cannabinoids. However, it is still considered a narcotic plant, making it hard to be accessed. Since the biosynthetic pathway of cannabinoids is disclosed, biotechnological methods can be employed to produce cannabinoids in heterologous systems. This would pave the way toward biosynthesizing any cannabinoid compound of interest, especially minor substances that are less produced by a plant but have a high medicinal value. In this context, microalgae have attracted increasing scientific interest given their unique potential for biopharmaceutical production. In the present review, the current knowledge on cannabinoid production in different hosts is summarized and the biotechnological potential of microalgae as an emerging platform for synthetic production is put in perspective. A critical survey of genetic requirements and various transformation approaches are also discussed. © 2022 Informa UK Limited, trading as Taylor %26 Francis Group.
Review
Generically Dependent Continuant
RDF description of Harnessing the advances of genetic engineering in microalgae for the production of cannabinoids - http://orbis.uaslp.mx/vivo/individual/scopus10558
Article
Information Content Entity